Concepedia

Andrea Hall

AH

Statistics

Publications

8

Citations

522

H-Index

8

Active since

2003

Affiliations

Senex Biotechnology (United States)(Current)

Cardiff University

Andrea Hall is an author at Senex Biotechnology (United States) specializing in pharmacy, medicinal chemistry, and antiviral therapy.

Publications per year

2003–2019

8

Publications

8

Characterization of a Protective Monoclonal AntibodyRecognizing <i>Staphylococcus aureus</i> MSCRAMM ProteinClumping FactorA

Andrea Hall, Paul Domanski, Pratiksha Patel et al. · Infection and Immunity · 2003 · 145 citations · Full text

, , +17

Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus

Christopher McGuigan, Karolina Madela, Mohamed Aljarah et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 99 citations

, , +9

INX-08189, a Phosphoramidate Prodrug of 6-<i>O</i>-Methyl-2′-<i>C</i>-Methyl Guanosine, Is a Potent Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic and Pharmacodynamic Properties

John Vernachio, Blair Bleiman, K. Dawn Bryant et al. · Antimicrobial Agents and Chemotherapy · 2011 · 84 citations · Full text

, , +17

Characterization of a Humanized Monoclonal Antibody Recognizing Clumping Factor A Expressed by <i>Staphylococcus aureus</i>

Paul Domanski, Pratiksha Patel, Arnold S. Bayer et al. · Infection and Immunity · 2005 · 74 citations · Full text

, , +17

Phosphoramidate ProTides of 2′-<i>C</i>-Methylguanosine as Highly Potent Inhibitors of Hepatitis C Virus. Study of Their in Vitro and in Vivo Properties

Christopher McGuigan, Arnaud Gilles, Karolina Madela et al. · Journal of Medicinal Chemistry · 2010 · 56 citations

, , +14

1–5 of 8